Alcon, Clara
Manzano-Muñoz, Albert http://orcid.org/0000-0003-4039-7391
Prada, Estela http://orcid.org/0000-0003-4611-1120
Mora, Jaume
Soriano, Aroa http://orcid.org/0000-0001-9659-1471
Guillén, Gabriela http://orcid.org/0000-0001-5632-2672
Gallego, Soledad http://orcid.org/0000-0002-4712-9624
Roma, Josep http://orcid.org/0000-0001-7692-6123
Samitier, Josep
Villanueva, Alberto http://orcid.org/0000-0001-5164-0006
Montero, Joan http://orcid.org/0000-0002-9192-4836
Funding for this research was provided by:
Fundación Cellex (NA, NA, NA, NA)
Ministerio de Economía y Competitividad (RYC-2015-18357)
Article History
Received: 14 April 2020
Revised: 4 August 2020
Accepted: 4 August 2020
First Online: 15 August 2020
Conflict of interest
: J.M. was a consultant for Oncoheroes Biosciences and Vivid Biosciences and is a board member for The Society for Functional Precision Medicine. A.V. is cofounder of the Spin-off of XenOPAT SL and has ownership interests. No potential conflicts of interest were disclosed by the other authors.